GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds. Alzforum, 30 Oct 2020 . GBA-Associated Synucleinopathies: Prime Candidates for Alpha-Synuclein Targeting Compounds.